Cubist Systematic Strategies, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$243,222
-92.3%
20,806
-89.0%
0.00%
-89.5%
Q1 2023$3,141,827
-49.2%
189,495
-43.0%
0.02%
-47.2%
Q4 2022$6,182,900
-24.9%
332,414
-48.2%
0.04%
-21.7%
Q3 2022$8,234,000
+231.3%
641,800
+81.0%
0.05%
+206.7%
Q2 2022$2,485,000
+0.0%
354,519
+18.3%
0.02%
-28.6%
Q1 2022$2,484,000
+7.3%
299,595
-12.3%
0.02%
-4.5%
Q4 2021$2,314,000
+288.9%
341,762
+204.6%
0.02%
+214.3%
Q3 2021$595,000
+72.5%
112,195
+86.8%
0.01%
+75.0%
Q2 2021$345,000
+148.2%
60,055
+99.1%
0.00%
+100.0%
Q1 2021$139,000
+32.4%
30,167
-3.7%
0.00%
+100.0%
Q4 2020$105,000
-11.0%
31,333
-20.8%
0.00%
-50.0%
Q3 2020$118,000
-35.9%
39,575
-0.5%
0.00%
-33.3%
Q2 2020$184,000
+80.4%
39,787
+46.6%
0.00%
+50.0%
Q4 2019$102,000
-67.5%
27,143
-66.8%
0.00%
-66.7%
Q2 2019$314,000
+912.9%
81,806
+537.4%
0.01%
+200.0%
Q1 2018$31,000
+40.9%
12,835
+11.6%
0.00%0.0%
Q1 2017$22,00011,5000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders